VTE in Hispanics. Not exactly the same as in White patients
In this matched registry analysis, self-identified Hispanic ethnicity was associated with modestly higher adjusted odds of recurrent VTE and major bleeding, but not mortality
New RIETE data suggest that a simple ECG can improve risk stratification in acute PE, helping identify patients at very low risk of early mortality
#RIETE#PulmonaryEmbolism#VTE#ECG
New RIETE data show that post-thrombotic syndrome is not a single phenotype: symptoms, signs and venous ulcers have different predictors and evolve differently over time
#RIETE#DVT#PTS#Thrombosis
New RIETE data show that cancer-associated upper-extremity DVT is not one disease: recurrence and bleeding risks vary substantially by cancer site
#RIETE#VTE#CancerAssociatedThrombosis#UEDVT
New RIETE data reveal an obesity paradox in cancer-associated VTE: obesity was associated with lower mortality, but higher major bleeding, with no difference in VTE recurrence
#RIETE#VTE#CancerAssociatedThrombosis
🩺 Una nueva cita para compartir conocimiento y avanzar en la atención a las personas con cronicidad y pluripatología.
Los próximos 15 y 16 de octubre celebraremos la XIII Reunión de Pacientes Crónicos Complejos – XVII Reunión del Grupo de Trabajo de Cronicidad y Pluripatología de la SEMI.
📍 Parador de Alcalá de Henares
🤝 Con el patrocinio de Boehringer Ingelheim.
¡Nos vemos en Alcalá de Henares!
👉 Consulta toda la información de la reunión: https://t.co/69ci3O2HZm
#SEMI #MedicinaInterna #Cronicidad #Pluripatología #PacientesCrónicosComplejos
RIETE in perspective.
Among major VTE registries, RIETE stands out for its size, international reach, and continuous enrollment since 2001. More than two decades of real-world data—and still growing.
A collective achievement made possible by investigators and patients worldwide
Arm DVT is not one disease.
New data from 4,979 RIETE patients show that outcomes differ substantially according to both cancer and catheter status. These distinctions may matter when individualizing anticoagulant therapy.
#RIETE#VTE#Thrombosis#UEDVT
New RIETE data: women with estrogen-associated VTE have a low risk of recurrence after stopping anticoagulation, but bleeding—particularly uterine bleeding—remains a concern during treatment.
#RIETE#VTE#WomensHealth
🔵 47.º Congreso Nacional de la SEMI
Enfermedad tromboembólica y cáncer
🎙️ Moderadora
Dra. Carme Font Puig @carmefontpuig
Servicio de Oncología Médica. Hospital Clínic. Barcelona.
👥 Ponentes
🔹 Despistaje de neoplasia oculta en el paciente con ETV
Dra. María Ortiz Rodríguez
Servicio de Medicina Interna. Hospital Clínic. Barcelona.
🔹 Tratamiento de la ETV en el paciente con cáncer
Dr. Pedro Ruiz Artacho
Servicio de Medicina Interna. Clínica Universidad de Navarra. Madrid.
🔹 Trombosis asociada a catéter venoso central en el paciente oncológico
Dr. Jesús González Olmedo
Servicio de Medicina Interna. Hospital Universitario 12 de Octubre. Madrid.
🗓️ 26 de noviembre, a las 13:30 h
#47SEMI #SEMICongreso #SEMI #somosSEMI #orgullodeserinternista #MedicinaInterna #internista
The NLR (neutrophil to lymphocyte ratio), a quick, cheap, and easily available test , confirms to be independently associated with 30-day all-cause mortality in patients with acute symptomatic PE
Among 10,059 patients with cancer and VTE, 3748 (37%) had obesity
Obese patients had lower 90-day (aOR, 0.68; 95% CI, 0.61-0.77) and 1-year mortality (aHR, 0.73; 95% CI, 0.67-0.79) but more major bleeding (90-day aOR, 1.38; 95% CI, 1.11-1.73; 1-year aHR, 1.36; 95% CI, 1.12-1.64)